Form S-D

 

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM SD

Specialized Disclosure Report

 

 

Pacific Biosciences of California, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

 

 

Delaware

 

001-34899

 

16-1590339

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1380 Willow Road

Menlo Park, California 94025

(Address of principal executive offices, including zip code)

(650) 521-8000

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

☒Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2014.

 

 

 

 

 

 

Section 1.Conflict minerals disclsosure

Item 1.01 Conflict Minerals Disclosure and Report, Exhibit

Pacific Biosciences of California, Inc. evaluated its current product lines and determined that certain products it manufactures or contracts to manufacture contain tin, tungsten, tantalum and/or gold. The survey of its suppliers determined that its supply chain is “DRC conflict undeterminable” and, as a result, it is filing a Conflict Minerals Report. A copy of Pacific Biosciences of California, Inc.’s Conflict Minerals Report is filed as Exhibit 1.01 hereto.  A copy of this Form SD and the Conflicts Minerals Report are publicly available at www.pacb.com.

 

Item 1.02  Exhibit

As specified in Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report for the calendar year ended December 31, 2014 as Exhibit 1.01 to this report.

 

Section 2.Exhibits

The following exhibits are filed as part of this report:

 

Item 2.01 Exhibits

Exhibit 1.01 — 2014 Conflict Minerals Report of Pacific Biosciences of California, Inc. as required by Items 1.01 and 1.02 of this Form.

 

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Susan

 

 

 

 

 

Pacific Biosciences of California, Inc.

 

 

By:

 

/s/ Susan K. Barnes        

 

 

Susan K. Barnes

Executive Vice President, Chief Financial Officer and Principal Accounting Officer

Date: May 29, 2015

 

EXHIBIT INDEX

 

Exhibit No.

Description

1.01

2014 Conflict Minerals Report of Pacific Biosciences of California, Inc.